Acer Medical Inc. (TPEX:6857)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
119.00
+2.00 (1.71%)
Jul 17, 2025, 1:32 PM CST
-33.89%
Market Cap1.81B
Revenue (ttm)50.16M
Net Income (ttm)-27.36M
Shares Out15.23M
EPS (ttm)-1.80
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume207
Average Volume835
Open117.50
Previous Close117.00
Day's Range117.50 - 119.00
52-Week Range113.00 - 192.00
Beta1.16
RSI48.78
Earnings DateJul 31, 2025

About Acer Medical

Acer Medical Inc. offers artificial intelligence, clinical data, and software for healthcare sector. It offers VeriSee DR, an AI-assisted diagnostic software for diabetic retinopathy identification; VeriSee AMD, an AI-assisted screening software for age-related macular degeneration identification; and VeriOsteo OP, an AI-assisted screening software for bone mineral density abnormalities. Acer Medical Inc. was founded in 2018 and is based in New Taipei City, Taiwan. [Read more]

Industry Medical - Diagnostics & Research
Sector Healthcare
Founded 2018
Employees 22
Stock Exchange Taipei Exchange
Ticker Symbol 6857
Full Company Profile

Financial Performance

In 2024, Acer Medical's revenue was 50.16 million, an increase of 82.73% compared to the previous year's 27.45 million. Losses were -27.36 million, -28.33% less than in 2023.

Financial Statements

News

There is no news available yet.